These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36239905)

  • 21. Topical Cantharidin in the Management of Molluscum Contagiosum: Preliminary Assessment of an Ether-free, Pharmaceutical-grade Formulation.
    Del Rosso JQ; Kircik L
    J Clin Aesthet Dermatol; 2019 Feb; 12(2):27-30. PubMed ID: 30881580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V; Cathcart S; Burkhart CN; Morrell DS
    Dermatol Ther; 2013; 26(6):445-51. PubMed ID: 24552407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molluscum Contagiosum: Epidemiology, Considerations, Treatment Options, and Therapeutic Gaps.
    Hebert AA; Bhatia N; Del Rosso JQ
    J Clin Aesthet Dermatol; 2023 Aug; 16(8 Suppl 1):S4-S11. PubMed ID: 37636018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of molluscum contagiosum with cantharidin: a practical approach.
    Mathes EF; Frieden IJ
    Pediatr Ann; 2010 Mar; 39(3):124-8, 130. PubMed ID: 20302243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cantharidin Topical Solution 0.7%: First Approval.
    Keam SJ
    Paediatr Drugs; 2024 Jan; 26(1):95-100. PubMed ID: 38007409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum.
    Khattab FM; Nasr MM
    J Dermatolog Treat; 2020 Dec; 31(8):850-854. PubMed ID: 31418621
    [No Abstract]   [Full Text] [Related]  

  • 27. SB206, a Nitric Oxide-Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance.
    Maeda-Chubachi T; Hebert D; Messersmith E; Siegfried EC
    JID Innov; 2021 Sep; 1(3):100019. PubMed ID: 34909721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R; Pan M; DeMoll E; Levitt J
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SB206, a New Topical Nitric Oxide-Releasing Drug on the Horizon for the Treatment of Molluscum Contagiosum and External Anogenital Warts.
    Belmesk L; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):412-413. PubMed ID: 32400176
    [No Abstract]   [Full Text] [Related]  

  • 30. Molluscum Contagiosum: An Update.
    Leung AKC; Barankin B; Hon KLE
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):22-31. PubMed ID: 28521677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome.
    Sławińska M; Hlebowicz M; Iżycka-Świeszewska E; Sikorska M; Sokołowska-Wojdyło M; Smiatacz T; Gesing M; Nowicki RJ; Sobjanek M
    Acta Dermatovenerol Croat; 2020 Dec; 28(7):233-235. PubMed ID: 33834996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cantharidin for molluscum contagiosum.
    Ogilvie-Turner K; Goldman RD
    Can Fam Physician; 2020 Jun; 66(6):419-420. PubMed ID: 32532721
    [No Abstract]   [Full Text] [Related]  

  • 33. Interventions for cutaneous molluscum contagiosum.
    van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of topical 10% potassium hydroxide for molluscum contagiosum: a systematic review and meta-analysis.
    Heo JY; Park TH; Kim WI
    J Dermatolog Treat; 2022 May; 33(3):1682-1690. PubMed ID: 33667150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA; Cathcart S; Morrell DS
    Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL; Orchard DC
    Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
    Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J; Morrell DS
    Pediatr Dermatol; 2009; 26(4):405-8. PubMed ID: 19689514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB; Sidbury R; Mancini AJ
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum.
    Eichenfield L; Hebert A; Mancini A; Rosen T; Weiss J
    J Drugs Dermatol; 2021 Nov; 20(11):1185-1190. PubMed ID: 34784125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.